Antibiotic susceptibility was studied in 175 clinical isolates of Listeria monocytogenes. There were no major changes in the susceptibility of strains between 1958 and 1982. Benzylpenicillin and ampicillin had MICs for 90% of the strains (MIC,0) of 0.5 ,ug/ml. Gentamicin also had good activity against L. monocytogenes, with an MIC,0 of 1.0 jg/ml. All the new ,B-lactamase-stable cephalosporins tested had relatively poor activity against L. monocytogenes. Of the bacteriostatic antibiotics, trimethoprim had by far the lowest MIC,. (0.06 pg/ml), and in combination with sulfamethoxazole (co-trimoxazole), it had an MIC," of 0.5 jig/ml. Both erythromycin and doxycycline had low MIC,.s (0.25 jig/mn).
and doxycycline had low MIC,.s (0.25 jig/mn).
Listeria monocytogenes is a widespread microorganism which occasionally infects humans and produces severe diseases, e.g., bacteremia and meningitis, that must be correctly treated. However, there is no general agreement on the optimal regimen for treatment. The antibiotics often suggested include tetracycline (2, 3), ampicillin (7, 16, 21) , penicillin (9, 18) , erythromycin (9) , and antibiotic combinations that show synergistic effects against L. monocytogenes strains (6, 17, 19, 27) . The purpose of the present study was to compare the in vitro activity of commonly used antibiotics with that of newer drugs against clinical isolates of L. monocytogenes isolated between 1958 (11) (12) (13) (14) (15) and the rest of which caine from other Swedish hospitals. (12) .
Serological typing was done by slide agglutination with absorbed 0 sera prepared by the method of Seeliger (25) . A total of 32% of the strains belonged to serotype 1, and 68% belonged to serotype 4b. After primary isolation, the strains were suspended in Horter medium (skim milk) (10) , dried in an Edward freeze dryer, and stored at 4°C. (1, 6, 8, 19, 20, 27) . Antibiotic therapy with a combination of antibiotics with possible synergism seems very attractive, as many patients with L. monocytogenes infections have defects in host defense tnechanisms. In our in vitro study, ampicillin and benzylpenicillin had MICs for 90% of the strains of 0.5 ,ug/ml, supporting their position as the drugs of choice for the treatment of Listeria meningitis. Gentamicin was also active, with an MIC for 90o of the strains of 1 ,ug/ml. Thus, combination therapy with benzylpenicillin and gentamicin seems to be the best choice.
Of the other antibiotics, trimethoprim had by far the lowest MIC for 90% of the strains (0.06 ,ug/ml), and trimethoprim in combination with sulfamethoxazole inhibited 90% of the L. monocytogenes strains at a low concentration of 0.5 ,g/ml. This combination might be an alternative choice for treatment, as it has a postulated bactericidal activity (26) . Erythromycin and tetracycline also had very low MICs.
Of the first-generation cephalosporins, cephaloridine and cefazolin had moderate activity against the tested strains, with MICs of 2 and 4 ,ug/ml, respectively. As previously reported, all the new second-or third-generation ,-lactamase-stable cephalosporins tested had relatively poor activity against L. monocytogenes (22, 24) . Imipenem inhibited 90% of the strains at a concentration of 4 ,ug/ml, which disagrees with the results of a broth dilution test that yielded MICs of less than 0.25 gu.g/ml (4 
